How to buy Globus Medical stock | $56.53

Globus Medical, Inc is a medical devices business based in the US. Globus Medical shares (GMED) are listed on the NYSE and all prices are listed in US Dollars. Globus Medical employs 2,000 staff and has a trailing 12-month revenue of around USD$747.4 million.

How to buy shares in Globus Medical

1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
3. Search for Globus Medical. Find the stock by name or ticker symbol: GMED. Research its history to confirm it's a solid investment against your financial goals.
4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Globus Medical reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
5. Decide on how many to buy. At last close price of USD$56.53, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Globus Medical, depending on your broker.
6. Check in on your investment. Congratulations, you own a part of Globus Medical. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Globus Medical share price

Use our graph to track the performance of GMED stocks over time.

Globus Medical shares at a glance

• Key figures

Information last updated 2020-10-20.

Latest market close	USD$56.53
52-week range	USD$33.41 - USD$60.15
50-day moving average	USD$53.0066
200-day moving average	USD$50.3483
Wall St. target price	USD$60.85
PE ratio	63.6322
Dividend yield	N/A (0%)
Earnings per share (TTM)	USD$0.875

Buy Globus Medical shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

Is it a good time to buy Globus Medical stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Globus Medical, Inc by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Globus Medical price performance over time

Historical closes compared with the close of $56.53 from 2020-11-16

1 week (2020-11-25)	-5.47%
1 month (2020-11-06)	4.55%
3 months (2020-09-04)	2.30%
6 months (2020-06-05)	1.65%

1 year (2019-12-05)	-0.63%
2 years (2018-12-04)	22.76%
3 years (2017-12-05)	40.31%
5 years (2015-12-04)	111.56%

Is Globus Medical under- or over-valued?

Valuing Globus Medical stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Globus Medical's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Globus Medical's P/E ratio

Globus Medical's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 64x. In other words, Globus Medical shares trade at around 64x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Globus Medical's PEG ratio

Globus Medical's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.9962. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Globus Medical's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Globus Medical's EBITDA

Globus Medical's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$157.1 million.

The EBITDA is a measure of a Globus Medical's overall financial performance and is widely used to measure a its profitability.

Globus Medical financials

Revenue TTM	USD$747.4 million
Operating margin TTM	13.35%
Gross profit TTM	USD$605.4 million
Return on assets TTM	4.37%
Return on equity TTM	6.78%
Profit margin	11.9%
Book value	$13.676
Market capitalisation	USD$5.3 billion

TTM: trailing 12 months

Shorting Globus Medical shares

There are currently 1.8 million Globus Medical shares held short by investors – that's known as Globus Medical's "short interest". This figure is 9.5% down from 2.0 million last month.

There are a few different ways that this level of interest in shorting Globus Medical shares can be evaluated.

Globus Medical's "short interest ratio" (SIR)

Globus Medical's "short interest ratio" (SIR) is the quantity of Globus Medical shares currently shorted divided by the average quantity of Globus Medical shares traded daily (recently around 549708.41121495). Globus Medical's SIR currently stands at 3.21. In other words for every 100,000 Globus Medical shares traded daily on the market, roughly 3210 shares are currently held short.

However Globus Medical's short interest can also be evaluated against the total number of Globus Medical shares, or, against the total number of tradable Globus Medical shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Globus Medical's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Globus Medical shares in existence, roughly 20 shares are currently held short) or 0.0273% of the tradable shares (for every 100,000 tradable Globus Medical shares, roughly 27 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Globus Medical.

Find out more about how you can short Globus Medical stock.

Globus Medical share dividends

We're not expecting Globus Medical to pay a dividend over the next 12 months.

Globus Medical share price volatility

Over the last 12 months, Globus Medical's shares have ranged in value from as little as $33.41 up to $60.15. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Globus Medical's is 0.9675. This would suggest that Globus Medical's shares are less volatile than average (for this exchange).

Globus Medical overview

Globus Medical, Inc., a medical device company, focuses on the development and commercialization of implants that heal patients with musculoskeletal disorders. Its spine product portfolio includes a range of implant and surgical approach options that can be used to treat degenerative, deformity, tumor, and trauma conditions affecting the spine from the occiput to the sacrum. The company also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and regenerative biologic products, such as allografts and synthetic alternatives that are adjunctive treatments used in combination with stabilizing implant hardware. In addition, it provides motion preservation technologies, such as dynamic stabilization, total disc replacement and interspinous distraction devices, and interventional pain management solutions to treat vertebral compression fractures; imaging, navigation, and robotic assisted surgery technology solutions; and hip and knee joint solutions, as well as distributes human cell, tissue, and cellular and tissue based products. Further, the company offers expandable spacer products, which include RISE, RISE-L, CALIBER, CALIBER-L, ALTERA, ELSA, ELSA-ATP, SABLE, MAGNIFY, MAGNIFY-S, FORTIFY, and XPand; CREO thoracolumbar stabilization platform that offers instruments and implants for treating pathologies; CREO MIS and CREO MCS, options designed for less invasive surgery and minimal muscle disruption; CREO Derotation and CREO Rod Link Reducer systems, which help to streamline various derotation maneuvers for deformity correction; CREO Addition that provides a range of connectors; and CREO Fenestrated, a cement augmented pedicle screw system for patients with advanced stage tumors and limited life expectancy, as well as QUARTEX, an occipito-cervico-thoracic stabilization system. Globus Medical, Inc. was founded in 2003 and is headquartered in Audubon, Pennsylvania.

Frequently asked questions

• What percentage of Globus Medical is owned by insiders or institutions?

  Currently 1.556% of Globus Medical shares are held by insiders and 94.71% by institutions.

• How many people work for Globus Medical?

  Latest data suggests 2,000 work at Globus Medical.

• When does the fiscal year end for Globus Medical?

  Globus Medical's fiscal year ends in December.

• Where is Globus Medical based?

  Globus Medical's address is: 2560 General Armistead Avenue, Audubon, PA, United States, 19403

• What is Globus Medical's ISIN number?

  Globus Medical's international securities identification number is: US3795772082

• What is Globus Medical's CUSIP number?

  Globus Medical's Committee on Uniform Securities Identification Procedures number is: 379577208